original ) (raw )Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial
Kristina Forslind
RMD Open, 2016
View PDFchevron_right
Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores
Lorenzo Cavagna , Francesco Saccardo
Joint Bone Spine, 2014
View PDFchevron_right
Reanalysis of the multi-biomarker disease activity score for assessing disease activity in the AMPLE study: Comment on the article by Fleischmann et al
vibeke strand
Arthritis & rheumatology (Hoboken, N.J.), 2016
View PDFchevron_right
AB0279 A Dynamic of the Multi-Biomarker Disease Activity Score in Methotrexate Incomplete Responders is Predictive for Clinical Response to Non-Biological or Biological Therapy in Early RA
Kristina Forslind
Annals of the Rheumatic Diseases
View PDFchevron_right
Pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial
Kristina Forslind
Annals of the rheumatic diseases, 2014
View PDFchevron_right
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment
Herman Mielants
Arthritis research & therapy, 2005
View PDFchevron_right
FRI0100 Determining minimum clinically important change in multi biomarker disease activity score associated with clinical improvement in methotrexate naÏve patients with early rheumatoid arthritis
Katerina Chatzidionysiou
Poster Presentations, 2017
View PDFchevron_right
Performances of Clinical Disease Activity Index ( CDAI ) and Simplified Disease Activity Index ( SDAI ) appear to be better than the gold standard Disease Assessment Score ( DAS ‐28‐ CRP ) to assess rheumatoid arthritis patients
Siddharth Das
International Journal of Rheumatic Diseases, 2017
View PDFchevron_right
Prognostic markers of clinical remission in early rheumatoid arthritis after two years of DMARDs in a clinical setting
Ivonne Vázquez
Clinical and experimental rheumatology
View PDFchevron_right
Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease
Klaus Machold
Rheumatology, 2006
View PDFchevron_right
Effect of baseline rheumatoid factor (RF) levels on DAS28-response to standard DMARD-combination treatment in patients with rheumatoid arthritis (RA)
Ashima Makol
Indian Journal of Rheumatology, 2009
View PDFchevron_right
Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
Oliver Fitzgerald
The Journal of Rheumatology, 2019
View PDFchevron_right
Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate
Jean-Claude Becker
Annals of the Rheumatic Diseases, 2009
View PDFchevron_right
Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease
Reem Hamdy Mohammed
SpringerPlus, 2015
View PDFchevron_right
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activity
Michael Centola
Arthritis Care & Research, 2012
View PDFchevron_right
The US7 score is an effective tool of monitoring in patients with rheumatoid arthritis over 6 months of Tocilizumab
Hanan RKAIN
Rheumatology and Orthopedic Medicine, 2019
View PDFchevron_right
Development of a Multi-Biomarker Disease Activity Test for Rheumatoid Arthritis
Michael Centola
PLoS ONE, 2013
View PDFchevron_right
Disease Activity Indices in Rheumatoid Arthritis: Comparative Performance to Detect Changes in Function, IL-6 Levels, and Radiographic Progression
Nuria Montes
Frontiers in Medicine
View PDFchevron_right
Multi-biomarker disease activity score: an objective tool for monitoring rheumatoid arthritis? A systematic review and meta-analysis
Emese Gunther , Anna A Ascsillán
Rheumatology
View PDFchevron_right
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study
Michael Centola
Rheumatology, 2013
View PDFchevron_right
Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan
Akira Kaneko
Annals of the Rheumatic Diseases, 2007
View PDFchevron_right
Levels, Clinical Disease Activity, and Response to Treatment in Early Rheumatoid Arthritis
Alessia Morelli
2016
View PDFchevron_right
Value of Disease Activity Score 28 (DAS28) and DAS28-3 compared to American College of Rheumatology-defined remission in rheumatoid arthritis
L. Carmona
The Journal of …, 2004
View PDFchevron_right
Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting
Juan Canete
Rheumatology, 2003
View PDFchevron_right
Is radiographic progression of late-onset rheumatoid arthritis different from young-onset rheumatoid arthritis? Results from the Swiss prospective observational cohort
A. Finckh
Rheumatology, 2014
View PDFchevron_right
Performance of a multi-biomarker score measuring rheumatoid arthritis disease activity in the CAMERA tight control study
Michael Centola
Annals of the Rheumatic Diseases, 2012
View PDFchevron_right
Low dose prednisolone therapy (LDPT) retards radiographically detectable destruction in early rheumatoid arthritis –
H. Zeidler
Zeitschrift für Rheumatologie, 2000
View PDFchevron_right
Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy
Ronan Mullan
Arthritis & …, 2007
View PDFchevron_right
Prognostic evaluation of early rheumatoid arthritis
Ieda Laurindo
Swiss medical weekly: …, 2010
View PDFchevron_right
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in …
Anne Peretz
Arthritis research & …, 2005
View PDFchevron_right
The DAS is the most specific measure, but a patient questionnaire is the most informative measure to assess rheumatoid arthritis
Theodore Pincus
The Journal of rheumatology, 2006
View PDFchevron_right
A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol
Alan Kivitz
Arthritis & Rheumatology, 2015
View PDFchevron_right
Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)
Jaap Fransen
Arthritis & Rheumatism, 2003
View PDFchevron_right